This inventor holds 40 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 7 EPO patents, primarily in Bone Treatment Compounds. Top assignees: Novo Nordisk A/s, Osteologix A/s, Universitéde Liége. Active years: 1997-2014.
Location History:
- Vedb.o slashed.k, DK (1998)
- Vedb.oe butted.k, DK (1999)
- Gentotte, DK (2000)
- Vedb.ae butted.k, DK (2000)
- Vedbaek, DK (1997 - 2001)
- DK-2820 Gentofte, DK (1998 - 2001)
- Gentofte, DE (2008)
- Gantofte, DK (2010)
- Gentofte, DK (1998 - 2014)
Company Filing History:
24 out of 1,801 
6 out of 6 
5 out of 86 
Years Active: 1997-2014
Areas of Expertise:
Title: The Innovative Contributions of Stephan Christgau
Introduction
Stephan Christgau, based in Gentofte, Denmark, is a prolific inventor with an impressive portfolio of 40 patents. His innovative work primarily focuses on the treatment and prophylaxis of bone and cartilage conditions, showcasing a commitment to advancing medical solutions.
Latest Patents
Among his notable recent patents is a groundbreaking combination treatment using a strontium-containing compound. This invention targets cartilage and bone conditions, notably by combining strontium with active substances that enhance bone density, heal fractures, and improve overall bone quality. Another significant patent addresses the treatment of necrotic bone conditions, presenting a method that utilizes strontium to treat osteonecrotic diseases in mammals. This includes conditions like idiopathic osteonecrosis and avascular necrosis, ensuring effective treatment through an innovative dosage regimen. Furthermore, he developed a method that combines strontium with therapeutic agents known to induce apoptosis or necrosis in bone cells, further expanding therapeutic options for patients with bone diseases.
Career Highlights
Stephan has made significant contributions to the biomedical field while working with renowned companies such as Novo Nordisk A/S and Osteologix A/S. His career is marked by a dedication to research and development, particularly in the areas of pharmacology and regenerative medicine, which has led to numerous advancements in treatment methods for bone health.
Collaborations
Throughout his career, Stephan has collaborated with various professionals, including esteemed coworkers Lene Nonboe Andersen and Markus Sakari Kauppinen. These collaborations have enhanced the scope of his research and contributed to the successful development of his patented inventions.
Conclusion
Stephan Christgau's innovative patents and dedication to addressing complex medical challenges have positioned him as a key figure in the field of bone and cartilage treatment. His work not only advances scientific knowledge but also offers hope and improved quality of life for many patients suffering from bone-related conditions.